Home / Medicine / Deconex ir

Deconex ir

Recorded active ingredients: Phenylephrine hydrochloride, Guaifenesin

Based on a snapshot of pillintrip.com listings. Country listings do not confirm current availability or registration. Sources and limitations · How matching works.

Countries
USA
Diseases
Fever Rhinitis Cold Hay Fever Blocked Nose Cough
Drug Actions
Antitussive

Medicines with the same recorded active ingredients

These listings match the full ingredient set recorded for Deconex ir. Strength, dosage form and route may differ or be missing. This does not establish interchangeability; confirm a suitable product with a pharmacist.

Aldex g Aquatab d Children's mucinex stuffy nose & cold D-phen 1000 Deconex Donatussin Donatussin (guaifenesin_phenylephrine hydrochloride) Donatussin drops Duravent pe Ed brongp Entex lq Gilphex tr J-max Liquibid d-r Liquibid pd-r Liquibid-pd Lusair Mucaphed Mucinex fast-max cold and sinus Mucusrelief sinus

Overdose

No information provided.

Contraindications

No information provided.

Undesirable effects

No information provided. Please see the WARNINGS AND PRECAUTIONS sections

Therapeutic indications

Purpose (in each tablet)
  • Expectorant
  • Nasal Decongestant
Uses

Temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or other respiratory allergies:

  • helps loosen phlegm and thin bronchial secretions to make coughs more productive
  • nasal congestion
  • runny nose
  • sneezing
  • itching of the nose or throat
  • itchy, watery eyes

Date of revision of the text

Jun 2016

Name of the medicinal product

Deconex IR Tablets

Qualitative and quantitative composition

Other Information

Tamper evident: do not use if tamper evident seal is broken or missing. Store at 15°-30°C (59°-86°F).

Deconex IR Tablets are a green, oval, scored tablet debossed POLY 716 on one side, plain on the other.

NDC 50991-736-90

Inactive Ingredients

FD&C Yellow No. 5, FD&C Blue No. 1, magnesium stearate, microcrystalline cellulose, sodium starch glycolate.

Questions? Comments? Call 1-800-882-1041

Manufactured for: Poly Pharmaceuticals, Huntsville, AL 35763. 1(800) 882-1041. Revised: Jun 2016

Special warnings and precautions for use

WARNINGS

Included as part of the PRECAUTIONS section.

PRECAUTIONS

Do not exceed recommended dosage.

A persistent cough may be a sign of a serious condition. If cough persists for more than 1 week, tends to recur, or is accompanied by fever, rash, or persistent headache, consult a doctor.

Ask a doctor before use if you have

  • a persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema, or if cough is accompanied by excessive phlegm
  • heart disease
  • high blood pressure
  • thyroid disease
  • diabetes
  • difficulty in urination due to enlargement of the prostate gland

Ask a doctor before use if you are taking sedatives or tranquilizers.

Stop use and ask a doctor if

  • nervousness, dizziness or sleeplessness occur

Ask a doctor or pharmacist before use

if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping
the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product

If pregnant or breast feeding, ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Dosage (Posology) and method of administration

Directions

Do not exceed recommended dosage.

Adults and children 12 years of age and over: 1 tablet every 4 hours, not to exceed 6 tablets in 24 hours.

Children 6 to under 12 years of age: ½ tablet every 4 hours, not to exceed 3 tablets in 24 hours or as directed by a doctor..

Children under 6 years of age: Consult a physician.

Interaction with other medicinal products and other forms of interaction

SIDE EFFECTS

No information provided. Please see the WARNINGS AND PRECAUTIONS sections

DRUG INTERACTIONS

No information provided.

Listed in 1 countries